Estimates Revisions Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
|
Market Closed -
TEL AVIV STOCK EXCHANGE
10:29:05 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 11,540.00 ILa | +3.78% |
|
+5.77% | +14.37% |
| 09-10 | Teva Pharmaceutical Prices $4.9 Billion Senior Notes Offering | MT |
| 09-09 | Leerink Partners Initiates Coverage on Teva Pharmaceutical Industries With Outperform Rating, $45 Price Target | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Teva Pharmaceutical Industries Limited(TEVA)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Teva Pharmaceutical Industries Limited(TEVA)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Teva Pharmaceutical Industries Limited(TEVA)
EBIT
Dividend / Share (DPS)
Data source:
Teva Pharmaceutical Industries Limited(TEVA)
Cash or Net Debt
Select your edition
All financial news and data tailored to specific country editions
